Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHS2401442	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs(4)	Generic Drug	2024-05-14					view
CYHS2302318	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs(4)	Generic Drug	2023-08-30					view
CYHS2301031	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs(4)	Generic Drug	2023-04-12					view
CYHS2300815	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs(4)	Generic Drug	2023-03-17					view
JYHB2200427	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2022-08-08		Boehringer Ingelheim International GmbH			view
JYHB2101089	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2021-05-11		Boehringer Ingelheim International GmbH			view
JYHB2002593	二甲双胍恩格列净片（Ⅴ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2020-12-18	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2021-01-08	view